TY - JOUR
T1 - National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants
AU - Danaei, Goodarz
AU - Finucane, Mariel M.
AU - Lin, John K.
AU - Singh, Gitanjali M.
AU - Paciorek, Christopher J.
AU - Cowan, Melanie J.
AU - Farzadfar, Farshad
AU - Stevens, Gretchen A.
AU - Lim, Stephen S.
AU - Riley, Leanne M.
AU - Ezzati, Majid
AU - AUTHOR GROUP
AU - Abdeen, Ziad
AU - Agyemang, Charles
AU - Al Nsour, Mohannad
AU - Ali, Mohamed M.
AU - Ambady, Ramachandran
AU - Babu, Bontha V.
AU - Barbagallo, Carlo M.
AU - Barceló, Alberto
AU - Barreto, Sandhi
AU - Barros, Henrique
AU - Bautista, Leonelo E.
AU - Bjerregaard, Peter
AU - Björkelund, Cecilia
AU - Bo, Simona
AU - Bobak, Martin
AU - Bonora, Enzo
AU - Botana, Manuel A.
AU - Bovet, Pascal
AU - Breckenkamp, Juergen
AU - Breteler, Monique M.
AU - Broda, Grazyna
AU - Brown, Ian J.
AU - Bursztyn, Michael
AU - de León, Antonio Cabrera
AU - Casiglia, Edoardo
AU - Castetbon, Katia
AU - Chatterji, Somnath
AU - Chen, Zhengming
AU - Chen, Chien-Jen
AU - Chua, Lily
AU - Cífková, Renata
AU - Cobiac, Linda J.
AU - Cooper, Richard S.
AU - Dankner, Rachel S.
AU - Dong, Guang-Hui
AU - Elliott, Paul
AU - Erem, Cihangir
AU - Esteghamati, Alireza
AU - Fan, Jian-Gao
PY - 2011
Y1 - 2011
N2 - Data for trends in blood pressure are needed to understand the effects of its dietary, lifestyle, and pharmacological determinants; set intervention priorities; and evaluate national programmes. However, few worldwide analyses of trends in blood pressure have been done. We estimated worldwide trends in population mean systolic blood pressure (SBP). We estimated trends and their uncertainties in mean SBP for adults 25 years and older in 199 countries and territories. We obtained data from published and unpublished health examination surveys and epidemiological studies (786 country-years and 5·4 million participants). For each sex, we used a Bayesian hierarchical model to estimate mean SBP by age, country, and year, accounting for whether a study was nationally representative. In 2008, age-standardised mean SBP worldwide was 128·1 mm Hg (95% uncertainty interval 126·7-129·4) in men and 124·4 mm Hg (123·0-125·9) in women. Globally, between 1980 and 2008, SBP decreased by 0·8 mm Hg per decade (-0·4 to 2·2, posterior probability of being a true decline=0·90) in men and 1·0 mm Hg per decade (-0·3 to 2·3, posterior probability=0·93) in women. Female SBP decreased by 3·5 mm Hg or more per decade in western Europe and Australasia (posterior probabilities ≥0·999). Male SBP fell most in high-income North America, by 2·8 mm Hg per decade (1·3-4·5, posterior probability >0·999), followed by Australasia and western Europe where it decreased by more than 2·0 mm Hg per decade (posterior probabilities >0·98). SBP rose in Oceania, east Africa, and south and southeast Asia for both sexes, and in west Africa for women, with the increases ranging 0·8-1·6 mm Hg per decade in men (posterior probabilities 0·72-0·91) and 1·0-2·7 mm Hg per decade for women (posterior probabilities 0·75-0·98). Female SBP was highest in some east and west African countries, with means of 135 mm Hg or greater. Male SBP was highest in Baltic and east and west African countries, where mean SBP reached 138 mm Hg or more. Men and women in western Europe had the highest SBP in high-income regions. On average, global population SBP decreased slightly since 1980, but trends varied significantly across regions and countries. SBP is currently highest in low-income and middle-income countries. Effective population-based and personal interventions should be targeted towards low-income and middle-income countries. Funding Bill & Melinda Gates Foundation and WHO
AB - Data for trends in blood pressure are needed to understand the effects of its dietary, lifestyle, and pharmacological determinants; set intervention priorities; and evaluate national programmes. However, few worldwide analyses of trends in blood pressure have been done. We estimated worldwide trends in population mean systolic blood pressure (SBP). We estimated trends and their uncertainties in mean SBP for adults 25 years and older in 199 countries and territories. We obtained data from published and unpublished health examination surveys and epidemiological studies (786 country-years and 5·4 million participants). For each sex, we used a Bayesian hierarchical model to estimate mean SBP by age, country, and year, accounting for whether a study was nationally representative. In 2008, age-standardised mean SBP worldwide was 128·1 mm Hg (95% uncertainty interval 126·7-129·4) in men and 124·4 mm Hg (123·0-125·9) in women. Globally, between 1980 and 2008, SBP decreased by 0·8 mm Hg per decade (-0·4 to 2·2, posterior probability of being a true decline=0·90) in men and 1·0 mm Hg per decade (-0·3 to 2·3, posterior probability=0·93) in women. Female SBP decreased by 3·5 mm Hg or more per decade in western Europe and Australasia (posterior probabilities ≥0·999). Male SBP fell most in high-income North America, by 2·8 mm Hg per decade (1·3-4·5, posterior probability >0·999), followed by Australasia and western Europe where it decreased by more than 2·0 mm Hg per decade (posterior probabilities >0·98). SBP rose in Oceania, east Africa, and south and southeast Asia for both sexes, and in west Africa for women, with the increases ranging 0·8-1·6 mm Hg per decade in men (posterior probabilities 0·72-0·91) and 1·0-2·7 mm Hg per decade for women (posterior probabilities 0·75-0·98). Female SBP was highest in some east and west African countries, with means of 135 mm Hg or greater. Male SBP was highest in Baltic and east and west African countries, where mean SBP reached 138 mm Hg or more. Men and women in western Europe had the highest SBP in high-income regions. On average, global population SBP decreased slightly since 1980, but trends varied significantly across regions and countries. SBP is currently highest in low-income and middle-income countries. Effective population-based and personal interventions should be targeted towards low-income and middle-income countries. Funding Bill & Melinda Gates Foundation and WHO
U2 - https://doi.org/10.1016/S0140-6736(10)62036-3
DO - https://doi.org/10.1016/S0140-6736(10)62036-3
M3 - Article
C2 - 21295844
SN - 0140-6736
VL - 377
SP - 568
EP - 577
JO - Lancet
JF - Lancet
IS - 9765
ER -